MAPT and Down syndrome: Further studies, including our ongoing work in the Neurodegeneration in Aging Down Syndrome study with tau-tracer [18F]-AV1451 and [11C]-PiB imaging, will help disentangle the differential contributions of Aβ and tau toward brain atrophy and disease progression.